Raymond James Financial Free cash flow increased by 1982.1% to $1.05B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1384.5%, from $71.00M to $1.05B. Over 3 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -30.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.37B | $4.53B | -$2.31B | $1.09B | $5.71B | -$4.52B | -$3.16B | -$666.00M | -$241.00M | $493.00M | $342.00M | $655.00M | $460.00M | $789.00M | $71.00M | $634.00M | $752.00M | -$56.00M | $1.05B |
| QoQ Change | — | +230.0% | -150.9% | +147.4% | +422.3% | -179.1% | +30.0% | +78.9% | +63.8% | +304.6% | -30.6% | +91.5% | -29.8% | +71.5% | -91.0% | +793.0% | +18.6% | -107.4% | >999% |
| YoY Change | — | — | — | — | +316.5% | -199.9% | -37.2% | -160.9% | -104.2% | +115.6% | +151.4% | +371.8% | — | +60.0% | -79.2% | -3.2% | +63.5% | -107.1% | >999% |